HIV/AIDS - Breakthrough discovery in HIV research opens path to new, better therapies
Can't see this email? View it online
   
  HIV/AIDS  
  The latest HIV/AIDS news from News Medical  
 Understanding HIV’s resistance to AntiretroviralsUnderstanding HIV’s resistance to Antiretrovirals
 
As of 2018, 37.9 million people worldwide are known to be living with HIV. This is a major epidemic with 1.7 million new infections in 2018 alone. These high rates of infection provide a large gene pool from which resistant strains can emerge. Although there are two variants of HIV which have overcome the species barrier, the HIV-1 variant is more virulent and widespread and therefore is the variant that will be discussed.
 
   Breakthrough discovery in HIV research opens path to new, better therapiesBreakthrough discovery in HIV research opens path to new, better therapies
 
New research on the human immunodeficiency virus (HIV) structure has revealed a promising novel drug target for treating it.
 
   Exploring mechanisms of resistance to HIV in people with sickle cell diseaseExploring mechanisms of resistance to HIV in people with sickle cell disease
 
Analysis supports reports that sickle cell disease causes lower HIV infection rate, but cell studies did not reveal a mechanism.
 
 Newly developed laboratory model helps reveal how HIV infection affects the brain
 
Newly developed laboratory model helps reveal how HIV infection affects the brainThough many negative repercussions of human immunodeficiency virus infection can be mitigated with the use of antiretroviral therapy, one area where medical advances haven't made as much progress is in the reduction of cognitive impacts.
 
 
 Depressive disorders in patients with HIV/AIDS often go unrecognized or untreated
 
Depressive disorders in patients with HIV/AIDS often go unrecognized or untreatedPeople living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry.
 
 
 A 'window of vulnerability' for re-infection with HIV after stem cell transplantation
 
A 'window of vulnerability' for re-infection with HIV after stem cell transplantationSome people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient's immune cells are eliminated during these transplantations.
 
 
 Majority of women prefer LAI HIV therapy over daily pills
 
Majority of women prefer LAI HIV therapy over daily pillsA new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over current daily pills.